-
FDA approved 22 new drugs in lower-than-average 2016
SILVER SPRING, Md. — The Food and Drug Administration’s Center for Drug Evaluation and Research’s number of new drug approvals came in low in 2016, according to the agency’s year-end review of the new therapies that passed regulatory muster. The number of drugs the FDA approved last year, 22, is less than half of the 45 approved in 2015 and lower than the average of the last 10 years of approvals, which is 29.
OncoGenex to acquire Achieve Life Science
BOTHEL, Wash., and VANCOUVER, British Columbia — OncoGenex Pharmaceuticals will acquire Achieve Life Science in all-stock transaction. OncoGenex is a publicly traded oncology biopharmaceutical company, while Achieve is a privately held specialty pharmaceutical provider.
Under terms of the agreement, expected to close in mid-2017, Achieve’s shareholders will own 75 percent of the combined company, while OncoGenex shareholders will own the remaining 25 percent.
